Lung Cancer Overview

LUNG CANCER, WHAT IS LUNG CANCER?

Lung cancer is the uncontrolled growth of abnormal cells in the lung. Normal lung tissue is made up of cells that are programmed by nature to create lungs of a certain shape and function. Sometimes the instructions to a cell go haywire and that cell and its offspring reproduce wildly, without regard for the shape and function of a lung. That wild reproduction can form tumours that clog up the lung and make it stop functioning as it should. Because of the large size of the lungs, cancer may grow for many years, undetected, without causing suspicion. In fact, lung cancer can spread outside the lungs without causing any symptoms at all.The majority of people who get lung cancer have been cigarette smokers, but not all people who smoke get lung cancer, many people who have never smoked before still get it.Some causes of lung cancer can include smoking, air pollution, vitamin A deficiency or genetic factors.

SYMPTOMS OF LUNG CANCER

Here are some symptoms of lung cancer-A cough is one of the more common symptoms and is likely to happen when a tumour grows and blocks an air passage.-Chest, shoulder, or back pain is another.-Shortness of breath, fatigue, repeated pneumonia or bronchitis, coughing up blood or swelling of the neck and face.The graph below shows some more symptoms and the frequency of each.

THE DIFFERENT TYPES OF LUNG CANCER

The type of cells found in a tumour determines the kind of cancer. The two main types of lung cancer are small cell and non-small cell. The term s small cell and non- small cell refer to the type of cell a doctor can see under the microscope, not to the size of the tumour. There are more than a dozen different kinds of lung cancer.Small cell carcinoma (also called oat cell carcinoma)This cancer usually starts in one of the larger breathing tubes, grows fairly rapidly, and is likely to be large by the time of diagnosis.Non small cell lung cancer: is made up of the following three subtypes:-Epidermoid carcinomaThis cancer usually starts in one of the larger breathing tubes and grows relatively slowly. The size of these tumours can range from very small to quite large.-Adenocarcinoma carcinomaThis lung cancer starts growing near the outside surface of the lung and may vary in both size and growth rate. Some slowly growing adenocarcinomas are call alveolar cell cancer.-Large cell carcinomaStarts near the surface of the lung, grows rapidly, and is usually large when diagnosed.The names of some of the uncommon types of lung cancer are carcinoid, cylindroma, mucoepidermoid, and malignant mesothelioma. Only about 5% to 10% of lung cancers are of these types.

WHO GETS LUNG CANCER

Studies show that people living in the United Kingdom have the highest risk of developing lung cancer the reason being is that the UK is a very industrialised country.

People at the highest risk of receiving lung cancer include:-Those living in a Westernised society.- Those who smoke.- Those who are 60 or over.- Those who live in an urban environment.

TREATMENT

Treatment for non-small cell cancer is usually surgery. The only times when an operation will not be useful is if:1. The cancer has spread outside the chest.2. If the cancer is pressing on the major airways of the chest.3. If the cancer is invading the trachea.4. If the cancer is invading the heart or major blood vessels.5. If there is fluid around the lung.6. Or if there is loss of voice.

Treatment of small-cell lung cancer can be chemotherapy, radiotherapy, surgery or immunotherapy.At the moment many scientists are trying to find a more reliable technique in curing lung cancer.




Lung Cancer News

6 May 2008 at 4:00am
VANCOUVER, WA (MARKET WIRE) The Caring Ambassadors Lung Cancer Program (CAP Lung Cancer) proudly announces the launch of the CAP Lung Cancer Internet site redesign. CAP Lung Cancer is pleased to offer the community this state-of-the-art resource. The redesigned site is more user-friendly, and introduces many new features and enhancements of existing tools and activities.
25 Apr 2008 at 7:00am
A groundbreaking free tool to help oncologists choose the best therapies for patients with non-small-cell lung cancer has been launched this week by scientists at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in Geneva, Switzerland.
24 Apr 2008 at 10:00pm
(European Society for Medical Oncology) A groundbreaking free tool to help oncologists choose the best therapies for patients with non-small-cell lung cancer has been launched this week by scientists at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology and the International Association for the Study of Lung Cancer in Geneva, Switzerland.
2 Apr 2008 at 3:55pm
Scientists conducting genome-wide association studies have found a region on chromosome 15 associated with the development of lung cancer. The studies may help to explain why some smokers get lung cancer and others don't.
31 Mar 2008 at 10:00pm
Researchers from Boston University School of Medicine have developed a new "clinicogenomic model" to accurately test for lung cancer. The model combines a specific gene expression for lung cancer as well as clinical risk factors. These findings currently appear online in the journal Cancer Prevention Research.
24 Apr 2008 at 10:00pm
(European Society for Medical Oncology) Papers presented at the 1st European Lung Cancer Conference, jointly organized by the European Society for Medical Oncology and the International Association for the Study of Lung Cancer in Geneva, Switzerland highlight emerging evidence that common viruses may contribute to the development of lung cancer.
24 Apr 2008 at 10:00pm
(European Society for Medical Oncology) New results on genetic techniques that are helping doctors diagnose and treat lung cancer were released today at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology and the International Association for the Study of Lung Cancer in Geneva, Switzerland.
14 Apr 2008 at 2:51am
OnApril 11, 2008, an announcement by Eli Lilly and Company (NYSE:LLY) indicated that European health authorities have approved theuse of ALIMTAŽ (pemetrexed for injection) for a histologically-baseduse in the first-line treatment of advanced non-small-cell lung cancer(NSCLC), the most common form of lung cancer.
2 Apr 2008 at 11:27pm
Three research groups announced Wednesday that they have identified a widely distributed genetic variation that appears to increase the chances of developing lung cancer.
3 Apr 2008 at 3:51am
Some smokers may be especially vulnerable to lung cancer because of a genetic variation in part of chromosome 15, new research shows.
26 Apr 2008 at 2:53am
Smoking is by far the leading risk factor for lung cancer, but new research suggests that common viruses, including one linked to cervical cancer, may also contribute to the development of the deadly disease.
25 Apr 2008 at 2:47am
An experimental vaccine that works by training the immune system to kill specific tumor cells is showing promise for the treatment of early lung cancer, researchers report.
21 Apr 2008 at 2:30am
Eli Lilly and Company (NYSE: LLY) announced that European health authorities have approved the use of ALIMTAŽ (pemetrexed for injection) for a histologically-based use in the first-line treatment of advanced non-small-cell lung cancer (NSCLC), the most common form of lung cancer.
16 May 2008 at 5:00am
Celecoxib, the anti-inflammatory medication also known by the trade name Celebrex, has proven to be safe and reduces a specific proliferation measurement of precancerous lesions in the lung, according to a study from The University of Texas M. D. Anderson Cancer Center.
3 Apr 2008 at 10:00pm
Experts from around the world are gathering in Geneva next month at a new conference that aims to improve lung cancer treatment and answer unsolved questions about a disease that kills 1.5 million people each year.